Fibrinogen Human, Human Thrombin - Fibrin Sealant (Tisseel)

Trade Name : TISSEEL

Baxter Healthcare Corporation

KIT, PLASMA DERIVATIVE

Strength

Delivery Process

Submit a Request

You can fill in a request for your medicine through the form provided. You can access the form by clicking on the ‘Get Price’ button.

We’ll Get in Touch

Once we review your request, we’ll send you an estimated price for the medicine within 2-5 days.

Confirmation and Payment

You can fill in a request for your medicine through the form provided. You can access the form by clicking on the ‘Get Price’ button.

Submit a Request

You can fill in a request for your medicine through the form provided. You can access the form by clicking on the ‘Get Price’ button.

Product information is meant for

Wholesalers Suppliers Exporters Doctors MOH Tender Supplies Hospitals Brand CROs Comparator Supplies Generic Cooperate Sourcing Individual Patients Indian Institutional Buyers

Disclaimer

Trade Marks displayed in compliance with provisions of: Trademark Act, 1999 u/s 30 and 30 (1) of "Fair use"

GNH India is WHO GDP and ISO 9001 2015 Certified Pharmaceutical Wholesaler/ Supplier/ Exporters/ Importer from India of Fibrinogen Human, Human Thrombin - Fibrin Sealant (Tisseel) which is also known as TISSEEL and Manufactured by Baxter Healthcare Corporation. It is available in strength of per ml. Read more

Fibrinogen Human, Human Thrombin - Fibrin Sealant (Tisseel) is supplied for Tenders/ Emergency imports/ Un - licensed, Specials, Orphan drug/ Name patient line/ RLD supplies/ Reference listed drugs/ Comparator Drug/ Bio-Similar/ Innovator samples For Clinical trials.  Click to know price.     Read less

Packaging and Delivery

Validated Cold Chain Shipment

We deliver your medicines through a validated cold chain shipment process. This process is used as these medicines need to manufactured, transported and stored at very specific temperatures, utilizing thermal and refrigerated packaging methods.

Inquire directly from our website and get 5% off on any medicine!

We deliver your medicines through a validated cold chain shipment process. This process is used as these medicines need to manufactured, transported and stored at very specific temperatures, utilizing thermal and refrigerated packaging methods.

Read more

About GNH

We deliver your medicines through a validated cold chain shipment process. This process is used as these medicines need to manufactured, transported and stored at very specific temperatures, utilizing thermal and refrigerated packaging methods.

We deliver your medicines through a validated cold chain shipment process. This process is used as these medicines need to manufactured, transported and stored at very specific temperatures, utilizing thermal and refrigerated packaging methods.

Read more
  • No data
  • Hemostasis:
  • Sealing:
  • Hemostasis:
  • Sealing:
  • FOR TOPICAL USE ONLY u2013 DO NOT INJECT
  • Vials and pre-filled syringes are for single-patient use only. Discard any unused product.
  • For Topical Use Only. Do Not Inject ()
  • 2.3n- 5.2
  • TISSEEL Kit (Freeze-Dried) is supplied as 2 mL, 4 mL and 10 mL (total volume) pack sizes with and without the DUPLOJECT Fibrin Sealant Preparation and Application System. TISSEEL Pre-Filled Syringe (Frozen) is supplied as 2 mL, 4 mL and 10 mL (total volume) pack sizes with the DUO Set (AST Syringe) or DUPLOJECT COMBI (PRIMA Syringe).
  • TISSEEL Kit (Freeze-Dried) is supplied as 2 mL, 4 mL and 10 mL (total volume) pack sizes with and without the DUPLOJECT Fibrin Sealant Preparation and Application System ()
  • TISSEEL Pre-filled Syringe (Frozen) is supplied as 2 mL, 4 mL and 10 mL (total volume) pack sizes with DUO Set (AST syringe) or DUPLOJECT COMBI (PRIMA syringe) ()
  • No data
  • 4.1n- 5.3
  • 4.2n- 5.1n- 6
  • No data
  • 4.2n- 5.1n- 6
  • EASYSPRAY n- DUPLOSPRAY MIS
  • 2n- 2
  • 2n- 5.2
  • 4.1n- 5.3n- 6.2
  • Hypersensitivity or allergic/anaphylactoid reactions have occurred ()
  • Oxidized cellulose-containing preparations can reduce the efficacy of TISSEEL and should not be used as carrier materials. No interaction studies have been performed.
  • Oxidized cellulose-containing preparations can reduce the efficacy of TISSEEL and should not be used as carrier materials ()
  • Pregnancy: No human or animal data. Use only if clearly needed ()
  • TISSEEL [Fibrin Sealant] is a two-component fibrin sealant made from pooled human plasma. When combined, the two components, Sealer Protein and Thrombin mimic the final stage of the blood coagulation cascade.
  • Sealer Protein (Human)n n- i
  • Thrombin (Human)n
  • Viral Clearancen- see n- Arrayn- ).
  • The virus reduction factors (expressed as log) of manufacturing steps for each of the viruses tested are shown in .
  • n.d. = not determined
  • HIV-1n- HAVn- BVDVn- PRVn- MMV
  • In addition, Human Parvovirus B19 (B19V) was used to investigate the upstream Thrombin precursor mass capture step, the Sealer Protein early manufacturing steps and the Thrombin and Sealer Protein vapor heating steps. Using quantitative PCR assays, the estimated B19V log reduction factors were: (a) 1.7 for the Thrombin precursor mass capture step, (b) 3.4 for Sealer Protein early manufacturing steps, (c) >4 for Thrombin vapor heat treatment and (d) 1.0 for Sealer Protein vapor heat treatment.
  • No data
  • Long-term animal studies to evaluate the carcinogenic potential of TISSEEL or studies to determine the effect of TISSEEL on fertility have not been performed.
  • No data
  • How Supplied
  • TISSEEL is supplied in the following pack sizes and presentations:
  • TISSEEL Kit contains one vial each of:
  • TISSEEL Pre-Filled Dual-Chambered Syringe contains:
  • Storage and Handlingn- TISSEEL Kit (Freeze-Dried)
  • TISSEEL Pre-filled Syringe (Frozen)n
  • Discuss the risks and benefits of this product with the patient since it is made from human plasma.
  • Instruct patients to consult their physician if symptoms of B19 virus infection appear (fever, drowsiness, chills and runny nose) followed about two weeks later by a rash and joint pain (sn n n
  • Manufactured For Baxter Healthcare Corporation n
  • Baxter, Artiss, Duo, Duploject, Duploject Combi, Duplospray, Easyspray, Fibrinotherm and Tisseel are trademarks of Baxter International Inc.
  • Fibrin SealantTISSEEL 2 mL
  • NDC 0338-8402-01
  • Vapor Heated, Solvent/Detergent Treated, Frozen
  • Baxter Logo
  • Temperature sensitive u2013 Do NOT expose above 37u00b0C (99u00b0F).
  • TOPICAL USE ONLY DO NOT INJECT
  • Read directions for thawing and application before use.
  • Store at u201320u00b0C (u20134u00b0F) or colder. Unopened pouches may bestored for up to 48 hours at room temperature (15 u2013 25u00b0C).
  • Do not refrigerate or re-freeze.
  • Rx Only
  • Contents:
  • Pre-filled syringe containing:
  • u2013 Sealer Protein Solution (1):
  • u2013 Thrombin Solution (2):
  • DMC
  • Manufactured forBaxter HealthcareCorporationn
  • U.S. License No. 1400736623
  • Lot No.:
  • Exp. Date:
  • P
  • 0736624
  • Fibrin Sealant n n
  • Vapor Heated, Solvent/Detergent Treated, Frozen
  • TOPICAL USE ONLY
  • 2 mL
  • N3 0338-8402-02 3
  • Fibrin Sealant n n
  • TOPICAL USE ONLY
  • 2 mL
  • Fibrin Sealant n n
  • Vapor Heated, Solvent/Detergent Treated, Frozen
  • NDC 0338-8402-02
  • Prefilled Syringe
  • 2 mL
  • TOPICAL USE ONLY
  • Contents:Pre-filled syringe containing:
  • Sealer Protein Solution:
  • Thrombin Solution:
  • The risks and benefits of this product should be discussed with the patient.
  • Rx Only
  • DO NOT INJECT
  • Store at u201320u00b0C (u20134u00b0F) or colder.
  • Read enclosed directions for thawing and application before use.
  • Unopened pouches may be stored for up to 48 hours at roomtemperature (15 u2013 25u00b0C).
  • Do not refrigerate or re-freeze.
  • Not made with natural rubber latex
  • For Single Use Only.
  • Baxter Logo
  • Fibrin Sealant n n
  • TOPICAL USE ONLY
  • 2 mL
  • Fibrin Sealant n n
  • TOPICAL USE ONLY
  • 2 mL
  • Baxter Logo
  • 736624
  • Fibrin Sealant n n
  • Vapor Heated, Solvent/Detergent Treated, Frozen
  • Pre-filled Syringe
  • 2 mL
  • TOPICAL USE ONLYDO NOT INJECT
  • U.S. Pat. No.: 5,962,405
  • Manufactured for Baxter Healthcare Corporationn
  • Reorder Number: 1501261
  • Baxter and Tisseel are trademarks of Baxter International Inc.
  • Baxter Logo
  • NDC 0338-4210-02
  • Fibrin SealantTISSEEL n- 2 mL
  • Vapor Heated, Solvent/Detergent Treated, Kit
  • Baxter Logo
  • NDC 0338-4210-02
  • 0103033842100284
  • Fibrin SealantTISSEEL n- 2 mL
  • Vapor Heated, Solvent/Detergent Treated, Kit
  • Contents:
  • Sealer Protein Concentrate
  • Fibrinolysis Inhibitor Solution
  • Thrombin
  • Calcium Chloride Solution,
  • The risks and benefits of this product should be discussedwith the patient.Read enclosed directions for reconstitution and applicationbefore use.Use within four hours of reconstitution.
  • NOT FOR INJECTION. For single use only.
  • Not made with natural rubber latex
  • Rx only
  • Manufactured for Baxter Healthcare Corporationn
  • U.S. License No. 140
  • Made in Austria
  • U.S. Pat. No.: 5,962,405
  • Baxter and Tisseel are trademarks of Baxter International Inc.
  • 736640
  • 736640
  • Fibrin SealantTISSEEL n- 2 mL
  • Vapor Heated, Solvent/Detergent Treated, Kit
  • 2 mL
  • Store at 2u00b0C to 25u00b0C (36u00b0F to 77u00b0F).Avoid freezing.
  • Baxter Logo
  • NDC 0338-4301-02
  • Fibrin SealantTISSEEL 2 mLVapor Heated, Solvent/Detergent Treated, Kit
  • Manufactured for Baxter Healthcare Corporationn
  • U.S. License No. 140
  • Made in Austria
  • Reorder Number: 1504514
  • Baxter, Duploject and Tisseel are trademarks of Baxter International Inc.
  • U.S. Pat. No.: 5,962,405
  • Baxter Logo
  • NDC 0338-4301-02
  • Fibrin SealantTISSEEL 2 mLVapor Heated, Solvent/Detergent Treated, Kit
  • TOPICAL USE ONLY
  • DO NOT INJECT
  • Baxter Logo
  • NDC 0338-4301-02
  • 0103033843010230
  • Fibrin SealantTISSEEL 2 mLVapor Heated, Solvent/Detergent Treated, Kit
  • Contents:
  • Sealer Protein Concentrate
  • Fibrinolysis Inhibitor Solution
  • Thrombin
  • Calcium Chloride Solution,
  • The risks and benefits of this product should be discussedwith the patient. Read enclosed directions forreconstitution and application before use. Use within fourhours of reconstitution.
  • NOT FOR INJECTION.
  • Not made with natural rubber latex
  • Rx only
  • 0736642
  • 0736642
  • N3 0338-4301-02 3
  • Baxter Label
  • DUO Set 2 ml / 4ml
  • Baxter AG
  • 0297
  • LOT
  • USA
  • Manufactured for:n Westlake Village, CA 91362 USA
  • Rx only, single use only, non-pyrogenic
  • Not made with natural rubber latex
  • AF082407A04
  • Baxter Logo
  • DUPLOJET 2 mL / 4 mL
  • Fibrin Sealant Preparation and Application System
  • Baxter Logo
  • DUPLOJET 2 mL / 4 mL
  • Fibrin Sealant Preparation and Application System
  • BAXTER, DUPLOJET and TISSEEL are trademarks ofBaxter International Inc., registered in the U.S. Patent andTrademark office.
  • Manufactured for: n n Westlake Village, CA 91362 USA
  • DUPLOJET 2 mL / 4 mLFibrin Sealant Preparation andApplication System
  • For Fibrin Sealant2 mL or 4 mL Kit
  • 2 mL4 mL
  • For the preparation and application of TISSEEL[Fibrin Sealant] 2 mL / 4 mL Kit.
  • STERILE u2013 SINGLE PATIENT USE ONLY u2013 DO NOT RESTERILIZE
  • Use separate devices for reconstruction of Sealer Protein Concentrateand Thrombin.
  • Rx only
  • Made in Austria
  • 000077
  • M000077
  • DUPLOJET 2 mL / 4 mLFibrin Sealant Preparation andApplication System
  • For Fibrin Sealant2 mL or 4 mL Kit
  • 2 mL4 mL
  • Arrayn- Baxter
  • 000239
  • DUPLOJECTFibrin Sealant Preparation and Application System
  • For the preparation and application of TISSEEL [Fibrin Sealant] kit.
  • Note: See TISSEEL [Fibrin Sealant] package insert for additional preparation andapplication instructions.
  • 1.0 Reconstitution Instructions for the Circulating Nurse (Using the FIBRINO-THERM Heating and Stirring Device)
  • 1.1 Turn on the warming unit of the FIBRINOTHERM device (amber switch).
  • 1.2 Open TISSEEL [Fibrin Sealant] kit and place all vials into the appropriately sized heating wells of the FIBRINOTHERM device.
  • 1.3 Place the Sealer Protein vial into the large magnetic stirring well fitted with the appropriately sized adapter ring (if necessary). Do not activate the stirring mechanism at this time. The indicator light will remain lit until a temperature of37u00b0C (98.6u00b0F) is reached. Allow several minutes for proper warming.
  • 1.4 Open Pack A of the DUPLOJECT Preparation and Application System andassemble the blue-scaled and black-scaled syringes with the needles provided.
  • 1.5 Remove the flip-off caps from the blue-capped Sealer Protein Concentrateand Fibrinolysis Inhibitor Solution vials and wipe with a non-iodine based dis-infectant.
  • 1.6 Using the blue-scaled syringe, withdraw the Fibrinolysis Inhibitor Solution from the vial, tilting the vial slightly to facilitate removal of all solution. Inject the Fibrinolysis Inhibitor Solution into the Sealer Protein Concentrate vial. Gentlyswirl the vial to ensure that the freeze-dried material is fully soaked. Note: Do not invert or inject air into vials.
  • 1.7 Place the Sealer Protein Concentrate vial in the stirring well and activate the stirring mechanism of the FIBRINOTHERM device (green switch). Reconstitutionis complete when no undissolved particles are visible. If Sealer Protein is not fully dissolved after 20 minutes, discard and prepare a fresh kit. Continue with steps 8through 11.
  • 1.8 Remove the flip-off caps from the black-capped Thrombin and Calcium ChlorideSolution vials and wipe with a non-iodine based disinfectant.
  • 1.9 Using the black-scaled syringe, withdraw the Calcium Chloride Solution from thevial, tilting the vial slightly to facilitate removal of all solution. Inject the CalciumChloride Solution into the Thrombin vial. Note: Do not invert or inject air into vials.
  • 1.10 Swirl contents of the Thrombin vial briefly and return it to an appropriately sizedheating well in the FIBRINOTHERM device.
  • 1.11 Leave the Sealer Protein and Thrombin vials in the FIBRINOTHERM device untilthe solutions are ready to be passed into the sterile field.
  • 2.0 Preparation Instructions for the Scrub Nurse
  • 2.1 Open Pack B of the DUPLOJECT Preparation and Application System into thesterile field.
  • 2.2 Open Packs 1, 2, and 3.
  • 2.3 Assemble the blue-scaled and black-scaled syringes with the needles provided.Note: For 5 mL DUPLOJECT systems, attach the larger needle to the blue-scaledsyringe.
  • 2.4 While the Circulating Nurse holds the vial slightly tilted, insert needle intovial (bevel side down) and withdraw all of the Sealer Protein Solution into theblue-scaled syringe using slow, constant aspiration. Discard needle in sharpscontainer.
  • 2.5 While the Circulating Nurse holds the vial slightly tilted, insert needle into vial(bevel side down) and withdraw all of the Thrombin Solution into the black-scaledsyringe using slow, constant aspiration. Discard needle in sharps container.
  • 2.6 Remove any air bubbles from the syringes and ensure both syringes contain the same volume.
  • 2.7 Snap the filled syringes into the two-syringe clip with the flanges in an up/downposition, as illustrated below.
  • 2.8 Attach the joining piece to the syringe nozzles, ensuring that both are firmlyseated. Secure the joining piece by fastening the retaining strap to the doublesyringe clip. Note: Align the syringe nozzles toward the middle for properattachment.
  • 2.9 Fit one of the application needles onto the joining piece. A second applicationneedle is provided in Pack 3 as a spare.
  • 2.10 DUPLOJECT Applicator is ready for use.
  • 2.11 If application of TISSEEL [Fibrin Sealant] is interrupted, replace the needleimmediately before application is resumed. Note: If the apertures of the joiningpiece become clogged, Pack 4 contains one spare joining piece and two additional application needles.
  • Rx OnlyDO NOT REUSE OR RESTERILIZE.DISPOSE OF CONTAMINATED AND SHARP COMPONENTS PROPERLY.
  • BAXTER, DUPLOJECT, FIBRINOTHERM and TISSEEL are trademarks of Baxter International Inc.,registered in the U.S. Patent and Trademark Office.
  • Baxter Healthcare CorporationWestlake Village, CA 91362 USA
  • Baxter Logo
  • Fibrin SealantTISSEEL 2 mL
  • NDC 0338-9560-01
  • Vapor Heated, Solvent/Detergent Treated, Frozen
  • Baxter Logo
  • Temperature sensitive u2013 Do NOT expose above 37u00b0C (99u00b0F).
  • TOPICAL USE ONLY DO NOT INJECT
  • Read directions for thawing and application before use.Store at u201320u00b0C (u20134u00b0F) or colder. Unopened pouchesmay be stored for up to 48 hours at room temperature(15 u2013 25u00b0C).
  • Do not refrigerate or re-freeze.
  • Rx Only
  • Contents:n 1 mL, sterileu2013 Sealer Protein (Human)u2013 Fibrinolysis Inhibitor (Aprotinin, Synthetic), 3000 KIU/mL
  • u2013 Thrombin Solution (2):
  • DMC
  • Barcode
  • Manufactured forBaxter HealthcareCorporationn
  • Lot No.:Exp. Date:P
  • 0740315
  • Fibrin SealantTISSEELVapor Heated, Solvent/Detergent Treated, FrozenTOPICAL USE ONLY
  • 3 03389 56001 2
  • 2 mL
  • Fibrin SealantTISSEELVapor Heated, Solvent/Detergent Treated, FrozenTOPICAL USE ONLYwith Pre-filled PRIMA Syringe
  • NDC 0338-9560-01
  • TOPICAL USE ONLY
  • Contents:Pre-filled syringe containing:Sealer Protein Solution: 1 mL, sterileu2013 Sealer Protein (Human)u2013 Fibrinolysis Inhibitor (Aprotinin, Synthetic), 3000 KIU /units /mL
  • Thrombin Solution: 1 mL, sterileu2013 Thrombin (Human), 500 units/mLu2013 Calcium Chloride, 40 u03bcmol /mL
  • The risks and benefits of this product shouldbe discussed with the patient.
  • Rx Only
  • DO NOT INJECT
  • Store at u201320u00b0C (u20134u00b0F) or colder.
  • Read enclosed directions for thawing andapplication before use.
  • Unopened pouches may be stored for up to48 hours at room temperature (15 u2013 25u00b0C).
  • Do not refrigerate or re-freeze.
  • Not made with natural rubber latexFor Single Patient Use Only.
  • Fibrin SealantTISSEELVapor Heated, Solvent/Detergent Treated, FrozenTOPICAL USE ONLY2 mL
  • Fibrin SealantTISSEELVapor Heated, Solvent/Detergent Treated, FrozenTOPICAL USE ONLY2 mL
  • Fibrin SealantTISSEELVapor Heated, Solvent/Detergent Treated, FrozenTOPICAL USE ONLY2 mL
  • Fibrin SealantTISSEELVapor Heated, Solvent/Detergent Treated, FrozenTOPICAL USE ONLYwith Pre-filled PRIMA Syringe
  • Placeholder for
  • Sticker
  • TOPICAL USE ONLY
  • DO NOT INJECT
  • U.S. Pat. No.: 5,962,405
  • Manufactured for Baxter Healthcare Corporation
  • Deerfield IL, 60015 USA
  • 1-888-229-0001
  • U.S. License No. 140
  • Made in Austria
  • Reorder Number: 1506078
  • Baxter and Tisseel are trademarks ofBaxter International Inc.
  • 2 mL
  • Baxter Logo
  • Baxter Logo
  • Fibrin SealantTISSEEL 4 mL
  • NDC 0338-9564-01
  • Vapor Heated, Solvent/Detergent Treated, Frozen
  • Baxter Logo
  • Temperature sensitive u2013 Do NOT expose above 37u00b0C (99u00b0F).
  • TOPICAL USE ONLY DO NOT INJECT
  • Read directions for thawing and application before use.Store at u201320u00b0C (u20134u00b0F) or colder. Unopened pouchesmay be stored for up to 48 hours at room temperature(15 u2013 25u00b0C).
  • Do not refrigerate or re-freeze.
  • Rx Only
  • Contents:n 2 mL, sterileu2013 Sealer Protein (Human)u2013 Fibrinolysis Inhibitor (Aprotinin,Synthetic), 3000 KIU/mL
  • u2013 Thrombin Solution (2):
  • DMC
  • Barcode
  • Manufactured forBaxter HealthcareCorporationn
  • Lot No.:Exp. Date:P
  • 0740319
  • Fibrin SealantTISSEELVapor Heated, Solvent/Detergent Treated, FrozenTOPICAL USE ONLY
  • 3 03389 56401 0
  • 4 mL
  • Fibrin SealantTISSEELVapor Heated, Solvent/Detergent Treated, FrozenTOPICAL USE ONLYwith Pre-filled PRIMA Syringe
  • NDC 0338-9564-01
  • TOPICAL USE ONLY
  • Contents:Pre-filled syringe containing:Sealer Protein Solution: 2 mL, sterileu2013 Sealer Protein (Human)u2013 Fibrinolysis Inhibitor (Aprotinin, Synthetic), 3000 KIU /units /mL
  • Thrombin Solution: 2 mL, sterileu2013 Thrombin (Human), 500 units/mLu2013 Calcium Chloride, 40 u03bcmol /mL
  • The risks and benefits of this product shouldbe discussed with the patient.
  • Rx Only
  • DO NOT INJECT
  • Store at u201320u00b0C (u20134u00b0F) or colder.
  • Read enclosed directions for thawing andapplication before use.
  • Unopened pouches may be stored for up to48 hours at room temperature (15 u2013 25u00b0C).
  • Do not refrigerate or re-freeze.
  • Not made with natural rubber latexFor Single Patient Use Only.
  • Fibrin SealantTISSEELVapor Heated, Solvent/Detergent Treated, FrozenTOPICAL USE ONLY4 mL
  • Fibrin SealantTISSEELVapor Heated, Solvent/Detergent Treated, FrozenTOPICAL USE ONLY4 mL
  • Fibrin SealantTISSEELVapor Heated, Solvent/Detergent Treated, FrozenTOPICAL USE ONLY4 mL
  • Fibrin SealantTISSEELVapor Heated, Solvent/Detergent Treated, FrozenTOPICAL USE ONLYwith Pre-filled PRIMA Syringe
  • Placeholder for
  • Sticker
  • TOPICAL USE ONLY
  • DO NOT INJECT
  • U.S. Pat. No.: 5,962,405
  • Manufactured for Baxter Healthcare Corporation
  • Deerfield IL, 60015 USA
  • 1-888-229-0001
  • U.S. License No. 140
  • Made in Austria
  • Reorder Number: 1506079
  • Baxter and Tisseel are trademarks ofBaxter International Inc.
  • 4 mL
  • Baxter Logo
  • Baxter Logo
  • Fibrin Sealant
  • TISSEEL 2 mL
  • NDC 0338-9568-01
  • Vapor Heated, Solvent/Detergent Treated, Frozen
  • Baxter Logo
  • Temperature sensitive u2013 Do NOT expose above 37u00b0C (99u00b0F).
  • TOPICAL USE ONLY DO NOT INJECT
  • Read directions for thawing and application before use.
  • Store at u201320u00b0C (u20134u00b0F) or colder. Unopened pouchesmay be stored for up to 48 hours at room temperature(15 u2013 25u00b0C).
  • Do not refrigerate or re-freeze.
  • Rx Only
  • Contents:
  • Pre-filled syringe containing:n 1 mL, sterileu2013 Sealer Protein (Human)u2013 Fibrinolysis Inhibitor (Aprotinin, Synthetic), 3000 KIU/mL
  • u2013 Thrombin Solution (2):
  • DMC
  • Barcode
  • Manufactured forBaxter HealthcareCorporationDeerfield, IL 60015 USAU.S. License No. 1400740322
  • Lot No.:Exp. Date:P
  • 0740323
  • Fibrin SealantTISSEELVapor Heated, Solvent/Detergent Treated, FrozenTOPICAL USE ONLY
  • 3 03389 56801 8
  • 10 mL
  • Fibrin SealantTISSEELVapor Heated, Solvent/Detergent Treated, FrozenTOPICAL USE ONLYwith Pre-filled PRIMA Syringe
  • NDC 0338-9568-01
  • TOPICAL USE ONLY
  • Contents:Pre-filled syringe containing:Sealer Protein Solution: 5 mL, sterileu2013 Sealer Protein (Human)u2013 Fibrinolysis Inhibitor (Aprotinin, Synthetic), 3000 KIU /units /mL
  • Thrombin Solution: 5 mL, sterileu2013 Thrombin (Human), 500 units/mLu2013 Calcium Chloride, 40 u03bcmol /mL
  • The risks and benefits of this product shouldbe discussed with the patient.
  • Rx Only
  • DO NOT INJECT
  • Store at u201320u00b0C (u20134u00b0F) or colder.
  • Read enclosed directions for thawing andapplication before use.
  • Unopened pouches may be stored for up to48 hours at room temperature (15 u2013 25u00b0C).
  • Do not refrigerate or re-freeze.
  • Not made with natural rubber latexFor Single Patient Use Only.
  • Fibrin SealantTISSEELVapor Heated, Solvent/Detergent Treated, FrozenTOPICAL USE ONLY10 mL
  • Fibrin SealantTISSEELVapor Heated, Solvent/Detergent Treated, FrozenTOPICAL USE ONLY10 mL
  • Fibrin SealantTISSEELVapor Heated, Solvent/Detergent Treated, FrozenTOPICAL USE ONLY10 mL
  • Fibrin SealantTISSEELVapor Heated, Solvent/Detergent Treated, FrozenTOPICAL USE ONLYwith Pre-filled PRIMA Syringe
  • Placeholder for
  • Sticker
  • TOPICAL USE ONLY
  • DO NOT INJECT
  • U.S. Pat. No.: 5,962,405
  • Manufactured for Baxter Healthcare Corporation
  • Deerfield IL, 60015 USA
  • 1-888-229-0001
  • U.S. License No. 140
  • Made in Austria
  • Reorder Number: 15060780
  • Baxter and Tisseel are trademarks ofBaxter International Inc.
  • 10 mL
  • Baxter Logo

Browse Our Services And Processes

Comparator Sourcing for Clinical Trials

Comparator Sourcing for Clinical Trials

GNH India brings over 10 years of experience in Comparator

Read More

Name Patient Supply

Name Patient Supply

Today, the exact cause for many rare diseases remains unknown

Read More

Validated Cold Chain Shipment

Validated Cold Chain Shipment

With shifting of pharma industry from synthetic molecules to biologic

Read More

Clinical Trials Supply

Clinical Trials Supply

STOP SOURCING..... START SMART SOURCING...... COME STRAIGHT TO THE SOURCE

Read More

Dossiers and Stability Studies

Dossiers and Stability Studies

STABILITY STUDIES STABILITY, BA / BE STUDIES Due to our active

Read More

Pharmaceutical Contract Manufacturing

Pharmaceutical Contract Manufacturing

GNH Provides Contract Manufacturing services for: Generic Medicines with following

Read More

Pricing

Pricing

PRICING POLICY Terms of sales are typically prepaid, unless otherwise

Read More

Disclaimer

Please see the Legal Notice for detailed terms and disclaimers. The Legal Notice governs the use of this Website and by accessing and using this Website you agree to be bound by and accept the Legal Notice.

Browse from other international pharmaceuticals

General

64020 Products

GNH India Brings to over 64036 Product SKUs from India all at 1 place with easy access and global deliveries.

US NDC

71247 Products

GNH India Brings to over 71252 Product SKUs from India all at 1 place with easy access and global deliveries.

Canadian DIN

51046 Products

GNH India Brings to over 51047 Product SKUs from India all at 1 place with easy access and global deliveries.

Swiss Drugs

150 Products

GNH India Brings to over 150 Product SKUs from India all at 1 place with easy access and global deliveries.

NZ Drugs

13296 Products

GNH Brings to over 13298 Product SKUs from India all at 1 place with easy access and global deliveries.

FAQ

Check out our delivery process

Can’t find what
you’re looking for?

Contact US
Pharmexcil
DB
FIEO-2016
SiteLock

Copyright © 2024 GNHIndia .com. All Rights Reserved. Please read Legal Notice for further details.

Disclaimer: Product names, logos, brands and other trademarks featured or referred to are the property of their respective trademark holders.